Most of them are structure-based inhibitors of MDR1, which is considered a prototypic ABC drug pump able to export (out of tumor cells) a large variety of drugs, such as doxorubicin, etoposide, paclitaxel, vinblastine and sorafenib [49]. This evidence concerns the gene ABCB1 and neoplasm.